治疗前恶病质指数与HPV阴性头颈鳞癌严重治疗毒性和总生存相关
本研究纳入353例在两家麦吉尔大学医院接受根治性手术的HPV阴性头颈鳞癌患者,评估治疗前恶病质指数(CXI)与严重治疗毒性及生存的关系。最低CXI五分位与严重治疗毒性独立相关(OR 2.04,95%CI 1.07-3.87),最低两个五分位与更差总生存相关(HR 3.00和2.83),CXI每增加100单位死亡风险降低8.9%(HR 0.91,95%CI 0.86-0.97)。
要点
- 低治疗前CXI与严重治疗毒性风险升高独立相关。
- 最低两个CXI五分位与更差总生存独立相关。
- CXI每增加100单位,死亡风险降低8.9%。
核心结论
- 低治疗前CXI独立关联严重治疗毒性和更差总生存,但多因素校正后与治疗不耐受及无病生存无独立关联。
研究设计与样本
- 回顾性研究纳入353例在两家麦吉尔大学医院(2015-2025)接受根治性手术的HPV阴性HNSCC患者。
- 治疗前CXI由骨骼肌指数、血清白蛋白和中性粒细胞与淋巴细胞比值计算。
- 采用多因素逻辑回归和Cox回归评估CXI与严重治疗毒性(CTCAE≥3级)、总生存和无病生存的关联。
主要发现
- 最低CXI五分位与严重治疗毒性独立相关(OR 2.04,95%CI 1.07-3.87)。
- 最低两个CXI五分位与更差总生存相关(HR 3.00和2.83)。
- CXI每增加100单位,死亡风险降低8.9%(HR 0.91,95%CI 0.86-0.97)。
- 多因素校正后CXI与治疗不耐受及无病生存无独立关联。
临床怎么用
- 治疗前CXI或可作为HPV阴性HNSCC患者严重治疗毒性和总生存的风险分层工具。
- 需进一步评估CXI的临床应用价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Cancer cachexia is characterized by skeletal muscle loss, poor nutrition, and systemic inflammation and is common in head and neck cancer. We evaluated whether the Cachexia Index (CXI) predicts treatment toxicity and survival in HPV-negative HNSCC. METHODS: This study included 353 patients undergoing curative-intent surgery at two McGill University hospitals (2015-2025). Pretreatment CXI was calculated using skeletal muscle index, serum albumin, and neutrophil-to-lymphocyte ratio. Multivariable logistic and Cox regression assessed associations with severe treatment toxicity (CTCAE grade ≥ 3), overall survival (OS), and disease-free survival. RESULTS: The lowest CXI quintile was independently associated with severe treatment toxicity (OR 2.04, 95% CI 1.07-3.87). The two lowest CXI quintiles were associated with worse OS (HR 3.00 and 2.83), while each 100-unit CXI increase reduced mortality risk by 8.9% (HR 0.91, 95% CI 0.86-0.97). CONCLUSIONS: Low pretreatment CXI was independently associated with severe treatment toxicity and poorer overall survival. However, CXI was not independently associated with treatment intolerance or disease-free survival after multivariable adjustment. These findings support further evaluation of CXI as a pretreatment risk stratification tool.
引用
- Savoia G, Hier MP, Sadeghi N, et al. Pretreatment Cachexia Index Is Associated With Severe Treatment Toxicity and Overall Survival in HPV-Negative Head and Neck Squamous Cell Carcinoma. Head Neck. 2026. PMID: 42819965. doi:10.1002/hed.70500
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。